XML 91 R78.htm IDEA: XBRL DOCUMENT v3.25.1
Note 16 - Stock Option and Purchase Plans (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 1,849,021 2,376,021
Share-Based Payment Arrangement, Expense $ 868,000 $ 813,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 1.02 $ 1.26
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period 226,500 525,600
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value $ 153,000 $ 312,000
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $ 1,432,000  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 1 year 9 months 18 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value $ 60,000 268,000
The 2015 Omnibus Plan [Member]    
Share Based Compensation Arrangement By Share Based Payment Award Award Lapsing Restrictions Period 3 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period 5 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 3 years  
Share-Based Payment Arrangement, Option [Member] | The 2015 Omnibus Plan [Member]    
Common Stock, Capital Shares Reserved for Future Issuance 3,476,021  
Share-Based Payment Arrangement, Option [Member] | The 2020 Omnibus Plan [Member]    
Common Stock, Capital Shares Reserved for Future Issuance 4,596,271  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 304,000 $ 0